Dishman Carbogen Amc
Ticker >

Dishman Carbogen Amc share price

Dishman Carbogen Amcis Ltd.

NSE: DCAL BSE: 540701 SECTOR: Pharmaceuticals & Drugs  69k   189   19

220.35
+1.05 (0.48%)
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 224.15

Today's Low

₹ 213.45

52 Week High

₹ 282.95

52 Week Low

₹ 113.25

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3454.72 Cr.

Enterprise Value

₹ 3976.14 Cr.

No. of Shares

15.68 Cr.

P/E

0

P/B

0.85

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  260.08

CASH

₹ 68.43 Cr.

DEBT

₹ 589.85 Cr.

Promoter Holding

59.32 %

EPS (TTM)

₹  -3.54

Sales Growth

31.29%

ROE

-1.41 %

ROCE

-0.81%

Profit Growth

-93.21 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year31.29%
3 Year-11.5%
5 Year-3.23%

Profit Growth

1 Year-86.59%
3 Year-215.19%
5 Year-209.69%

ROE%

1 Year-1.41%
3 Year-2.29%
5 Year-0.98%

ROCE %

1 Year-0.81%
3 Year-1.39%
5 Year0.02%

Debt/Equity

0.1434

Price to Cash Flow

-65.31

Interest Cover Ratio

-0.660911602209945

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 59.32 0
Sep 2023 59.32 0
Jun 2023 59.32 0
Mar 2023 59.32 0
Dec 2022 59.32 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 59.32%.

 Limitations

  • The company has shown a poor profit growth of -215.186766172892% for the Past 3 years.
  • The company has shown a poor revenue growth of -11.4993295474807% for the Past 3 years.
  • Company has a poor ROE of -2.29021149763185% over the past 3 years.
  • Company has a poor ROCE of -1.38570735633445% over the past 3 years
  • Company has low Interest coverage ratio of -0.660911602209945.
  • Company has negative cash flow from operations of -52.9.
  • The company is trading at a high EV/EBITDA of 48.2629.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 78.4 113.13 69.55 59.72 86.82
Total Expenditure 81.6 106.78 74.57 62.64 83.65
Operating Profit -3.2 6.35 -5.02 -2.92 3.17
Other Income 12.36 14.79 14.44 38.71 13.11
Interest 14.66 17.03 17.76 17.42 17.14
Depreciation 2.89 23.45 24.69 24.58 26.22
Exceptional Items -2 0 0 -3.05 0
Profit Before Tax -10.39 -19.34 -33.03 -9.26 -27.08
Tax -3.85 -9.11 -11.7 -3.48 -8.9
Profit After Tax -6.54 -10.23 -21.33 -5.78 -18.18
Adjusted EPS (Rs) -0.42 -0.65 -1.36 -0.37 -1.16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 549.47 580.74 200.32 306.61 402.55
Total Expenditure 355.68 407.18 253.11 272.82 394.79
Operating Profit 193.79 173.56 -52.79 33.79 7.76
Other Income 71.68 69.57 66.29 66.11 52.16
Interest 47.43 47.02 34.17 37.23 57.92
Depreciation 136.31 140.65 141.35 140.07 96.2
Exceptional Items 0 0 0 -5.91 -2
Profit Before Tax 81.73 55.46 -162.02 -83.31 -96.2
Tax 25.72 16.94 64.12 -52.84 -37.33
Net Profit 56.01 38.52 -232.81 -31.55 -58.87
Adjusted EPS (Rs.) 3.47 2.46 -14.42 -1.94 -3.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 32.28 31.38 31.36 31.36 31.36
Total Reserves 4860.09 4764.47 4643.26 4200.42 4082.95
Borrowings 202.73 137.9 144.41 134.42 162.57
Other N/C liabilities 195.08 356.7 348.96 444.04 409.68
Current liabilities 525.93 620.44 530.88 551.19 641.6
Total Liabilities 5816.11 5910.89 5698.87 5361.43 5328.16
Assets
Net Block 1715.32 1632.53 1509.65 1355.98 1382.3
Capital WIP 37.86 57.14 79.36 114.12 141.88
Intangible WIP 31.92 31.71 41.84 3.65 1.01
Investments 2886.97 2843.1 2814.87 2811.09 2837.36
Loans & Advances 406.44 576.27 529.74 310.14 315.19
Other N/C Assets 1.32 5.45 0.35 0.66 0.81
Current Assets 736.28 764.69 723.06 765.79 649.61
Total Assets 5816.11 5910.89 5698.87 5361.43 5328.16
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 81.73 55.46 -168.69 -84.39 -96.2
Adjustment 122.26 135.32 128.11 117.32 100.96
Changes in Assets & Liabilities -64.57 24.14 46.25 200.55 -54.11
Tax Paid -19.69 -18.24 -7.18 -6.13 -3.55
Operating Cash Flow 119.73 196.68 -1.51 227.35 -52.9
Investing Cash Flow -24.17 -74.3 62.07 -172.67 40.71
Financing Cash Flow -85.32 -124.07 -70.53 -46.16 1.38
Net Cash Flow 10.24 -1.69 -9.97 8.52 -10.81

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 59.32 59.32 59.32 59.32 59.32
adimans technologies llp 59.32 59.32 59.32 59.32 59.32
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 40.68 40.68 40.68 40.68 40.68
hbm healthcare investment... 3.55 3.55 3.55 3.55 3.55
hsbc flexi cap fund 1.52 1.52 1.52 1.52 1.52
icici prudential pharma h... - - 1.38 1.73 1.88
investor education and pr... - 0.01 0.01 0.01 0.01
llp 0.15 0.23 - 0.30 0.30
massachusetts institute o... 1.02 1.90 1.95 1.95 1.95
mukul mahavir agrawal 3.51 4.27 5.23 5.23 5.23
aditya birla sun life tru... 1.31 - - - -
investor education and pr... 0.01 - - - -
rekha rakesh jhunjhunwala... 1.63 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Dishman Carbogen Amc - Quaterly Results14 Feb 2024, 7:01PM Dishman Carbogen Amc - Quaterly Results14 Feb 2024, 7:01PM Dishman Carbogen Amcis informs about disclosure3 Feb 2024, 1:46PM Dishman Carbogen Amc - Quaterly Results8 Nov 2023, 7:21PM Dishman Carbogen Amc - Quaterly Results8 Nov 2023, 7:21PM Dishman Carbogen Amcis informs about closure of trading window 22 Sep 2023, 5:19PM Dishman Carbogen Amc - Quaterly Results9 Aug 2023, 6:12PM Dishman Carbogen Amc - Quaterly Results9 Aug 2023, 6:12PM Dishman Carbogen Amc - Quaterly Results23 May 2023, 4:57PM Dishman Carbogen Amc - Quaterly Results23 May 2023, 4:57PM Dishman Carbogen Amcis informs about board meeting 15 May 2023, 5:16PM Dishman Carbogen Amcis’ arm completes USFDA’s inspection at Switzerland manufacturing site 16 Feb 2023, 4:58PM Dishman Carbogen Amcis informs about transcript of earnings call15 Feb 2023, 4:32PM Dishman Carbogen Amc - Quaterly Results10 Feb 2023, 4:12PM Dishman Carbogen Amc - Quaterly Results10 Feb 2023, 4:12PM Dishman Carbogen Amc - Quaterly Results10 Feb 2023, 4:12PM Dishman Carbogen Amcis informs about board meeting 12 Jan 2023, 4:48PM Dishman Carbogen Amcis informs about credit rating22 Dec 2022, 3:25PM Dishman Carbogen Amc - Quaterly Results11 Nov 2022, 3:47PM Dishman Carbogen Amc - Quaterly Results11 Nov 2022, 3:47PM Dishman Carbogen Amcis’ arm completes Swissmedic inspection of facility in Switzerland 29 Sep 2022, 12:17PM Dishman Carbogen Amcis informs about conference call10 Aug 2022, 4:58PM Dishman Carbogen Amcis informs about investor presentation10 Aug 2022, 12:25PM Dishman Carbogen Amc - Quaterly Results9 Aug 2022, 6:39PM Dishman Carbogen Amc - Quaterly Results9 Aug 2022, 6:39PM Dishman Carbogen Amcis informs about closure of trading window28 Jun 2022, 3:35PM Dishman Carbogen Amcis informs about newspaper advertisement23 Jun 2022, 4:53PM Dishman Carbogen Amcis informs about annual secretarial compliance report30 May 2022, 1:50PM Dishman Carbogen Amc - Quaterly Results10 May 2022, 9:23PM Dishman Carbogen Amc - Quaterly Results10 May 2022, 9:23PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amcis informs about compliances certificate10 Jan 2022, 1:45PM Dishman Carbogen Amcis informs about press release28 Oct 2021, 1:14PM Dishman Carbogen Amcis planning to invest $50 million in France to set up new facility 21 Oct 2021, 10:29AM Dishman Carbogen Amcis informs about confirmation certificate7 Oct 2021, 4:31PM Dishman Carbogen Amcis’ arm enters into co- investment agreement with European customers25 Aug 2021, 11:08AM Dishman Carbogen Amcis informs about conference call12 Aug 2021, 4:57PM Dishman Carbogen Amcis informs about confirmation certificate12 Jul 2021, 3:19PM Dishman Carbogen Amcis informs about analyst meet 26 May 2021, 4:05PM Dishman Carbogen Amcis unveils successful results on study that uncovers treatment for vitamin D deficiency 21 May 2021, 2:31PM Dishman Carbogen Amcis informs about non-applicability of large corporate entity17 May 2021, 2:01PM Dishman Carbogen Amcis informs about outcome of board meeting12 May 2021, 12:34PM Dishman Carbogen Amcis enters into agreement with Veritas10 May 2021, 11:26AM Dishman Carbogen Amcis’ arm enters into joint funding agreement with longstanding Japan based customer 29 Apr 2021, 10:58AM Dishman Carbogen Amcis’ arm declares new expansion plans in Switzerland, France14 Aug 2020, 10:24AM Dishman Carbogen Amcis informs about investor presentation4 Jun 2020, 3:57PM

Dishman Carbogen Amc Stock Price Analysis and Quick Research Report. Is Dishman Carbogen Amc an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dishman Carbogen Amc and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Dishman Carbogen Amc cash from the operating activity was Rs -52.9 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dishman Carbogen Amc has a Debt to Equity ratio of 0.1434 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dishman Carbogen Amc , the EPS growth was -93.212227254014 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dishman Carbogen Amc has OPM of 1.92771084337349 % which is a bad sign for profitability.
     
  • ROE: Dishman Carbogen Amc have a poor ROE of -1.41072046910589 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Dishman Carbogen Amc is Rs 221.05. One can use valuation calculators of ticker to know if Dishman Carbogen Amc share price is undervalued or overvalued.
Last Updated on:
Brief about Dishman Carbogen Amc

Dishman Carbogen Amcis Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Dishman Carbogen Amcis Ltd. is a leading global contract research and manufacturing organization (CRMO) that focuses on the development and manufacturing of intermediates, APIs (active pharmaceutical ingredients), and finished dosage forms. With a rich history spanning several decades, Dishman Carbogen Amcis has established itself as a trusted partner in the pharmaceutical and life sciences industry.

Dishman Carbogen Amcis Ltd. - Share Price

Explore the latest share price of Dishman Carbogen Amcis Ltd. and track its performance in the stock market. Our website offers a user-friendly interface that allows you to stay updated with real-time stock prices, historical data, and key performance indicators.

Dishman Carbogen Amcis Ltd. - Balance Sheet

Gain insights into Dishman Carbogen Amcis Ltd.'s financial position through a comprehensive analysis of its balance sheet. Assess the company's assets, liabilities, and shareholders' equity to evaluate its overall financial health.

Dishman Carbogen Amcis Ltd. - Annual Report

Access Dishman Carbogen Amcis Ltd.'s annual reports on our website to review their performance throughout the year. These reports provide a detailed overview of the company's operations, financial results, and strategic initiatives. Stay informed about the company's achievements, challenges, and future prospects.

Dishman Carbogen Amcis Ltd. - Dividend

Discover Dishman Carbogen Amcis Ltd.'s dividend history and track the company's dividend payouts over time. Our website provides dividend information, including the dividend yield and dividend payment dates, enabling you to make informed investment decisions.

Dishman Carbogen Amcis Ltd. - Quarterly Result

Stay updated with Dishman Carbogen Amcis Ltd.'s quarterly results and analyze the company's financial performance for each reporting period. Our website offers downloadable quarterly reports that provide a comprehensive overview of the company's revenue, expenses, and profitability.

Dishman Carbogen Amcis Ltd. - Stock Price

Monitor Dishman Carbogen Amcis Ltd.'s stock price and track its movement in the market. Our website offers interactive stock charts and technical analysis tools to help you analyze historical price trends and make informed investment decisions.

Dishman Carbogen Amcis Ltd. - Price Chart

Our website provides detailed price charts for Dishman Carbogen Amcis Ltd., allowing you to visualize the stock's price movement over different timeframes. Analyze historical price patterns, spot trends, and identify potential investment opportunities using our pre-built screening tools.

Dishman Carbogen Amcis Ltd. - News

Stay informed about recent developments and news related to Dishman Carbogen Amcis Ltd. Our website curates the latest news articles and press releases, providing you with up-to-date information on the company's activities, collaborations, regulatory updates, and more.

Dishman Carbogen Amcis Ltd. - Concall Transcripts

Access Dishman Carbogen Amcis Ltd.'s con call transcripts on our website. These transcripts provide detailed insights into the company's conference calls with investors, allowing you to understand the management's perspective on the company's performance, future plans, and industry trends.

Dishman Carbogen Amcis Ltd. - Investor Presentations

Explore Dishman Carbogen Amcis Ltd.'s investor presentations to gain deeper insights into the company's strategy, market positioning, and growth potential. Our website provides downloadable investor presentations that showcase the company's achievements, financial highlights, and future outlook.

Dishman Carbogen Amcis Ltd. - Promoters

Learn about Dishman Carbogen Amcis Ltd.'s promoters and their contribution to the company's growth and success. Understand their vision, leadership, and strategic direction, which play a crucial role in shaping the company's future.

Dishman Carbogen Amcis Ltd. - Shareholders

Explore Dishman Carbogen Amcis Ltd.'s shareholder structure and understand the ownership pattern of the company. Gain insights into the major shareholders, institutional investors, and public investors who hold shares in Dishman Carbogen Amcis Ltd.

At our website, we offer pre-built screening tools that enable long-term stock investors to perform detailed stock analysis. Our tools, such as DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis, allow you to calculate fair value, assess the company's financial health, and make informed investment decisions.

Furthermore, we provide downloadable annual reports, concall transcripts, investor presentations, credit ratings, and research reports for Dishman Carbogen Amcis Ltd., ensuring that you have access to comprehensive information to aid your stock analysis.

Please note that the content is written in a technical tone to cater to the needs of long-term stock investors seeking in-depth stock analysis.

Read More
X